Therapeutic response and side effects of repeated radioligand therapy with (177)Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer

Prostate-specific membrane antigen (PSMA) is highly expressed on prostate epithelial cells and strongly up-regulated in prostate cancer (PC), making it an optimal target for the treatment of metastasized PC. Radioligand therapy (RLT) with (177)Lu-PSMA-DKFZ-617 (Lu-PSMA) is a targeted therapy for met...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadzadehfar, Hojjat, Eppard, Elisabeth, Kürpig, Stefan, Fimmers, Rolf, Yordanova, Anna, Schlenkhoff, Carl Diedrich, Gärtner, Florian, Rogenhofer, Sebastian, Essler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914299/
https://www.ncbi.nlm.nih.gov/pubmed/26871285
http://dx.doi.org/10.18632/oncotarget.7245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914299/
https://www.ncbi.nlm.nih.gov/pubmed/26871285
http://dx.doi.org/10.18632/oncotarget.7245

Ejemplares similares